Immune modulation therapy in the management of bortezomib-induced peripheral neuropathy

Peripheral neuropathy (PN) is one of the most common side effects of bortezomib therapy. The majority of bortezomib-related PN is a sensory neuropathy of mild to moderate degree, and is reversible after dose reduction or discontinuation. However, occasionally bortezomib-induced neuropathy can be sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeter, Ashley, Kang, Yubin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514086/
https://www.ncbi.nlm.nih.gov/pubmed/23211009
http://dx.doi.org/10.1186/2162-3619-1-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514086/
https://www.ncbi.nlm.nih.gov/pubmed/23211009
http://dx.doi.org/10.1186/2162-3619-1-20

Ejemplares similares